Genetics of immune-mediated inflammatory diseases

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• Immune-mediated inflammatory diseases (IMIDs) represent a significant global health burden due to chronic inflammation and comorbidities.
• Genetic studies reveal substantial overlap in predisposition loci across various IMIDs.
• Understanding this genetic overlap is crucial for identifying therapeutic targets and repurposing treatments.

Purpose of the Study:

• To investigate the genetic clustering of different immune-mediated inflammatory diseases.
• To explore the relationship between genetic architecture and disease classification (autoantibody-positive vs. autoantibody-negative).
• To correlate genetic clusters with known responses to biological therapies.

Main Methods:

• Genome-wide association studies (GWAS) were analyzed to identify shared genetic loci.
• Hierarchical clustering was applied to genetic data to group IMIDs based on shared risk variants.
• Disease classifications, including autoantibody status, were correlated with identified genetic clusters.

Main Results:

• A clear genetic clustering emerged, separating autoantibody-mediated autoimmune diseases from autoantibody-negative IMIDs.
• Autoantibody-negative diseases, including psoriasis, psoriatic arthritis, Crohn's disease, and ankylosing spondylitis, formed a distinct 'seronegative' genetic cluster.
• The observed genetic clustering largely aligned with established responses to current biological therapies, though some anomalies were noted.

Conclusions:

• Genetic analysis provides a framework for understanding the shared etiology of IMIDs.
• Distinct genetic clusters suggest different underlying pathogenic mechanisms for autoantibody-positive and autoantibody-negative IMIDs.
• These findings may guide the development of targeted therapies and optimize treatment strategies by considering genetic profiles.